58 search results for: coexisting diseases
Barrier Breakdown: The Role of Type 2 Inflammation in AD and Atopic Sensitization
Dr. Jeff Yu presents the clinical presentation of pediatric AD and highlights how type 2 inflammation contributes to symptoms and development of atopic comorbidities such as food allergy and asthma at PeDRA 2025
The Type 2 Interface: Unifying AD, CSU, and PN Pathophysiology and Dispelling Common Misconceptions
This symposium highlights the central role of type 2 inflammation in atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria and dismantles prevalent scientific misconceptions about these inflammatory skin conditions with lively discussion from Drs Jason Hawkes, Lakshi Aldredge and Diego Dasilva.
Shedding Light on PN: Confronting Misconception
Dr. Naiem Issa debunks common misconceptions in prurigo nodularis with key clinical insights.
Misconception on AD Pathomechanisms
Dr. Jason Hawkes provides key pathophysiologic insights and debunks common misconceptions surrounding atopic dermatitis.
Clarifying CSU: Separating Facts from Misconceptions
Dr. Diego Dasliva untangles popular misconceptions surrounding chronic spontaneous urticaria.
Dispelling Persistent Myths About PN
Dr. Lakshi Aldredge sets the record straight regarding common misconceptions about prurigo nodularis.
AD: Challenging the Conventional Narrative
Dr. Ahuva Cices provides key pathophysiologic insights and dispels common misconceptions surrounding atopic dermatitis.
Challenging Assumptions: Clarifying Type 2 Inflammation Across AD, PN, and CSU
In this webinar, Drs. David Cotter, Daniel Butler, and Walter Liszewski share key clinical insights, highlighting the central role of type 2 inflammation across atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria while addressing prevalent scientific misconceptions.
From Itch to Lesions: The Type 2 Inflammatory Link in AD, PN, and CSU
Dr. David Cotter discusses how atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis present uniquely in practice—and how type 2 inflammation links these distinct disease states.
Atopic and Nonatopic Comorbidities in AD and the Importance of Early Intervention
In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Amy Paller reviews the increased risk of atopic and nonatopic comorbidities associated with atopic dermatitis and discusses the potential of early intervention to mitigate their development.
